Compare Citius Pharmaceuticals Inc (CTXR) vs iShares MSCI South Africa ETF (EZA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs iShares MSCI South Africa ETF — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M), while iShares MSCI South Africa ETF trades at $63.48. The key difference: iShares MSCI South Africa ETF is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | EZA | |
|---|---|---|
Market Cap | $14.83M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.82 | $81.60 |
52-Week Low | $0.53 | $52.86 |
Enterprise Value | $11.05M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About iShares MSCI South Africa ETF
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →
